PRODUCT Properties
Melting point: | 232-233 °C(lit.) |
Boiling point: | 299.7±35.0 °C(Predicted) |
Density | 1.149 (estimate) |
refractive index | 1.5480 (estimate) |
Flash point: | >230 °F |
storage temp. | -20°C |
solubility | H2O: soluble |
pka | 2.22, 8.87, 10.86(at 25℃) |
form | solid |
color | White to Off-White |
optical activity | [α]/D 0±1°, c = 1 in H2O |
Merck | 14,4734 |
BRN | 1721683 |
Stability: | Stable. Combustible. Incompatible with strong oxidizing agents. |
InChIKey | FFFHZYDWPBMWHY-UHFFFAOYSA-N |
LogP | 0.220 (est) |
CAS DataBase Reference | 454-29-5(CAS DataBase Reference) |
Description and Uses
DL-Homocysteine has been used to induce hyperhomocysteinemia in Sprague–Dawley rats. It has also been used to study the effects of hyperhomocysteinemia on atherosclerosis in apolipoprotein E-deficient mice.
Safety
Symbol(GHS) | GHS07,GHS08,GHS09 |
Signal word | Danger |
Hazard statements | H315-H319-H413-H372 |
Precautionary statements | P501-P273-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |
Safety Statements | 22-24/25 |
WGK Germany | 3 |
RTECS | MT0175000 |
F | 10-23 |
HS Code | 29309090 |
Toxicity | LD50 intraperitoneal in mouse: 500mg/kg |